Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Briacell Therapeutics Corp T.BCT

Alternate Symbol(s):  BCTX | BCTXW

Healthcare Biotechnology
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted... see more

Recent & Breaking News (TSX:BCT)

BriaCell Breast Cancer Survival Data: 13.3 Months Versus 7.2-9.8 Months

GlobeNewswire October 21, 2020

BriaCell to Present Clinical Findings at the 2020 San Antonio Breast Cancer Symposium®, December 9 - 11

GlobeNewswire October 6, 2020

Note from BriaCell Management - October is Breast Cancer Awareness Month

GlobeNewswire October 1, 2020

BriaCell to Present at the 3rd Annual Biologics World Nordic 2020

GlobeNewswire September 15, 2020

BriaCell Awarded Research Grant from Wiseman Cancer Research Foundation

GlobeNewswire September 4, 2020

BriaCell Therapeutics Corp. Announces Completion of Shares for Debt Issuance

GlobeNewswire August 17, 2020

BriaCell Presents Clinical and Scientific Findings at the Annual Symposium of Society of Surgical Oncology 2020

GlobeNewswire August 17, 2020

Briacell Therapeutics Corp. Announces Shares for Debt Issuance

GlobeNewswire August 11, 2020

BriaCell Files Provisional Patent Application for Novel Treatment and Diagnosis of Coronavirus Disease

GlobeNewswire June 24, 2020

BriaCell Announces Presentation of Clinical and Scientific Findings at AACR Annual Meeting

GlobeNewswire June 22, 2020

BriaCell CEO to Present at 3rd Annual Next-Gen Immuno-Oncology Congress in June

GlobeNewswire June 9, 2020

BriaCell Presents Clinical Findings at 2020 American Society of Clinical Oncology (ASCO) Meeting

GlobeNewswire May 29, 2020

BriaCell Files Patent Application for Novel Immune Therapies for Multiple Disease Indications

GlobeNewswire May 20, 2020

BriaCell Announces Presentation and Abstract Publication at 2020 American Society of Clinical Oncology (ASCO) Meeting

GlobeNewswire May 14, 2020

BriaCell Continues Business and Clinical Operations During COVID-19 Pandemic

GlobeNewswire May 12, 2020

BriaCell Files Patent Application for Novel Therapeutics for Cancer

GlobeNewswire April 27, 2020

BriaCell Files New Provisional Patent Application for Antibody-Based Treatment of Infectious Diseases

GlobeNewswire April 21, 2020

UPDATE - BriaCell Files Coronavirus Immunotherapy Patent

GlobeNewswire April 14, 2020

BriaCell Files Coronavirus Immunotherapy Patent

GlobeNewswire April 14, 2020

BriaCell to Present Clinical Data at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting May 29

GlobeNewswire March 31, 2020